Two Sigma Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Sell |
|
|||||
|
2025
Q1 | $1.58M | Buy |
|
|||||
|
2024
Q4 | $347K | Sell |
|
|||||
|
2024
Q3 | $634K | Sell |
|
|||||
|
2024
Q2 | $1.52M | Sell |
|
|||||
|
2024
Q1 | $2.08M | Sell |
|
|||||
|
2023
Q4 | $2.67M | Sell |
|
|||||
|
2023
Q3 | $1.91M | Buy |
|
|||||
|
2023
Q2 | $1.16M | Buy |
|
|||||
|
2023
Q1 | $444K | Buy |
|
|||||
|
2022
Q4 | $498K | Buy |
|
|||||
|
2022
Q3 | $117K | Sell |
|
|||||
|
2022
Q2 | $567K | Sell |
|
|||||
|
2022
Q1 | $966K | Sell |
|
|||||
|
2021
Q4 | $1.5M | Buy |
|
|||||
|
2021
Q3 | $848K | Buy |
|
|||||
|
2021
Q2 | $277K | Sell |
|
|||||
|
2021
Q1 | $1.81M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $183K | Sell |
|
|||||
|
2020
Q2 | $1.13M | Sell |
|
|||||
|
2020
Q1 | $1.08M | Buy |
|
|||||
|
2019
Q4 | $1.41M | Buy |
|
|||||
|
2019
Q3 | $785K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $4.23M | Buy |
|